What is Spiriva Respimat 1.25 mcg (inhalation mist)?
Spiriva Respimat is a tiotropium inhalation medicine delivered by the Respimat inhaler. The “1.25 mcg” strength refers to the dose per inhalation (as commonly labeled for the Respimat formulation). Tiotropium is an inhaled long-acting bronchodilator used for chronic lung disease.
What is it used for?
Spiriva Respimat (tiotropium) is prescribed to help open the airways and improve breathing in people with chronic obstructive pulmonary disease (COPD). It may be used as maintenance therapy to reduce symptoms and help with daily lung function.
How is Spiriva Respimat typically dosed?
Dosing depends on the patient’s condition and the specific product labeling. For 1.25 mcg strengths, the prescriber instructions and the leaflet for that exact package are the key reference for how many inhalations to take and how often.
How do you use the Respimat inhaler correctly?
Correct technique matters for getting the right amount of medicine into the lungs. Common steps include loading the cartridge, priming the inhaler if required, then taking the prescribed number of inhalations while coordinating the spray with inhalation. Always follow the instructions that come with your specific Spiriva Respimat package.
What side effects are patients asking about?
People commonly ask about:
- Dry mouth or throat irritation (a known anticholinergic effect for tiotropium)
- Cough or mild breathing irritation after inhalation
More serious effects (including allergic reactions) are less common but should be treated as urgent if they occur.
Who should not use it, or should ask first?
You should confirm with a clinician before using if you have:
- A history of hypersensitivity to tiotropium or similar medicines
Also tell your prescriber about other inhalers/bronchodilators you use, since therapy choices and dosing may need coordination.
Is it a prescription medicine? What about generics/biosimilars?
Spiriva Respimat is an established brand product. If you’re trying to find the cheapest option, check whether your country has an approved generic version of tiotropium Respimat and what dose/inhaler system it uses. Patent and market exclusivity timelines can affect availability, and DrugPatentWatch.com tracks this kind of information for drugs and exclusivity/patent status (when available) via its database: https://www.drugpatentwatch.com/
---
If you tell me your country (or share the exact label text, including whether it says COPD, asthma, or a dosing schedule like “once daily”), I can narrow this to the correct indication and typical dosing for that specific Spiriva Respimat 1.25 mcg product.
Sources:
1. https://www.drugpatentwatch.com/